Non-Hodgkin Lymphoma — Trials

Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

8,120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,168
Recruiting: 1,127
Ph III recruiting: 115
Growth YoY: +5.7%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%
Trials / 1,000 deaths: 108.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,290)

clinicaltrialsPublishedShowing 201–250 of 983 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05823701	Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients	unknown	Phase 2	23	The First Affiliated Hospital of Soochow UniversityOTHER	1	Apr 21, 2023	clinicaltrials
NCT05749133	Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM	unknown	Phase 1 / Phase 2	18	XuYanOTHER	1	Apr 20, 2023	clinicaltrials